Calla Lily Clinical Care is a British women’s health startup that has developed the proprietary Callavid® platform for intravaginal drug delivery. Initial target indications are in fertility and pregnancy, where the company seeks to offer the world’s first drug-device combo product to help prevent miscarriages, and for IVF luteal phase support.
